Cargando…
Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports
Background. Ewing sarcoma family of tumors (ESFT) are rare but deadly cancers of unknown etiology. Few risk factors have been identified. This study was undertaken to ascertain any possible association between exposure to therapeutic drugs and ESFT. Methods. This is a retrospective, descriptive stud...
Autores principales: | Cope, Judith U., Reaman, Gregory H., Tonning, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439508/ https://www.ncbi.nlm.nih.gov/pubmed/26064078 http://dx.doi.org/10.1155/2015/948159 |
Ejemplares similares
-
Primary Occipital Ewing's Sarcoma with Subsequent Spinal Seeding
por: Alqahtani, Ali, et al.
Publicado: (2017) -
Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018) -
Ewing Sarcoma and Ewing-Like Sarcoma and the Role of NKX2.2 Immunoreactivity
por: Ullah, Asad, et al.
Publicado: (2021) -
Targeted Therapy in Ewing Sarcoma
por: Lissat, A., et al.
Publicado: (2012) -
Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)